Cytokinetics CYTK
NASDAQ CYTK
$56.80 -1.73 (-2.96%)
As of: Nov 12, 2026 · 12:16 PM EST

Cytokinetics (CYTK) Cost of Revenue (2018 - 2026)

Updated

Cytokinetics (CYTK) recorded Cost of Revenue of $454,000 in Q3 2026, down 83.4% from the prior quarter.

Analysis

Cytokinetics (CYTK) Cost of Revenue (2018 - 2026) Analysis & Trends

On a TTM basis, Cytokinetics' Cost of Revenue came in at $3.35 million as of Sep 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Cytokinetics 7.83 Bn 3.24 Bn 47.10 Mn 454,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 454,000.00
Jun 30, 2026 2.73 Mn
Mar 31, 2026 160,000.00
Dec 31, 2025 79.35 Mn
Dec 31, 2024 13.45 Mn
Sep 30, 2024 463,000.00
Jun 30, 2024 249,000.00
Mar 31, 2024 835,000.00
Dec 31, 2023 672,000.00
Sep 30, 2023 378,000.00
Jun 30, 2023 867,000.00
Mar 31, 2023 2.50 Mn
Sep 30, 2022 2.52 Mn
Jun 30, 2022 87.00 Mn
Mar 31, 2022 1.15 Mn
Dec 31, 2021 45.03 Mn
Sep 30, 2021 5.00 Mn
Jun 30, 2021 2.84 Mn
Mar 31, 2021 6.55 Mn
Sep 30, 2020 36.50 Mn
API Access

Cytokinetics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CYTK&period=max&api_key=YOUR_API_KEY